1.Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus

Cai, Z, Wong, CK, Ka     More...

Cai, Z, Wong, CK, Kam, NW, Dong, J, Jiao, D, Chu, M, Lam, CWK, Tam, LS     Less

LUPUS[0961-2033], Published 2015, Volume 24, Issue 12, Pages 1257-1266

收錄情况： WOS SCOPUS

WOS核心合集引用: 33  2023影響因子:  1.9  发表年影響因子:  2.118 

2.Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease

Tam, LS, Li, EK, Lam     More...

Tam, LS, Li, EK, Lam, CWK, Tomlinson, B     Less

LUPUS[0961-2033], Published 2000, Volume 9, Issue 6, Pages 413-416

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2023影響因子:  1.9  发表年影響因子:  2.514 

3.Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus

Wong, CK, Ho, CY, Li     More...

Wong, CK, Ho, CY, Li, EK, Lam, CWK     Less

LUPUS[0961-2033], Published 2000, Volume 9, Issue 8, Pages 589-593

收錄情况： WOS SCOPUS

WOS核心合集引用: 413  2023影響因子:  1.9  发表年影響因子:  2.514 

4.Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus

Tam, LS, Li, EK, Won     More...

Tam, LS, Li, EK, Wong, CK, Lam, CWK, Szeto, CC     Less

LUPUS[0961-2033], Published 2004, Volume 13, Issue 8, Pages 601-604

收錄情况： WOS SCOPUS

WOS核心合集引用: 77  2023影響因子:  1.9  发表年影響因子:  1.942